Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.

Hepatic arterial floxuridine (HAI) in 35 patients with systemic fluorouracil/folinic acid-resistant colorectal liver metastases achieved a 14% partial response and 26% disease stabilization rate, with a median response duration of 7 months from onset of HAI.

Detalles Bibliográficos
Autores principales: Fordy, C., Glover, C., Davies, M. M., Allen-Mersh, T. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063159/
https://www.ncbi.nlm.nih.gov/pubmed/9792150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063159/
https://www.ncbi.nlm.nih.gov/pubmed/9792150

Ejemplares similares